课题基金 / 基金详情

Research for the role of calcium-sensing receptor in parathyroid gland and bone

Research for the role of calcium-sensing receptor in parathyroid gland and bone
甲状旁腺和骨中钙敏感受体的作用研究
批准号:
12671087
负责人:
SUGIMOTO Toshitsugu
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

SUGIMOTO Toshitsugu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The down-regulation of both calcium-sensing receptor (CaSR) and vitamin D receptor (VDR) in parathyroid (PT) glands of secondary hyperparathyroidism (HPT) caused by chronic renal failure has been associated with parathyroid hormone (PTH) hypersecretion as well as PT hypergrowth. The present study was performed to clarify the predominance of decreased CaSr and VDR in the high proliferative activity of PT glands. We obtained evidence that the decrease in CaSR expression is associated with the high proliferative activity of PT glands in secondary HPT, independently of the decreased VDR. Similar relationship was also observed in primary HPT. We also reported two cases of familial hypocalciuric hypercalcemia whose parathyroid glands were enlarged. Analysis of DNA sequence and receptor function revealed inactivated multations of CaSR (R220W, R648stop). Moreover, in primary culture of human parathyroid cells, high concentration of calcium as well as CaSR agonists inhibited PT proliferation. T … More he present findings indicate an important role of CaSR in the regulation of PT proliferation as well as PTH secretion. Primary and secondary HPT are heterogeneous diseases in the clinical course and severity. We raised the hypothesis that CaSR polymorphisms might be associated with the magnitude of PTH secretion and the clinical severity of primary and secondary HPT. In the present study, we analyzed the relationship between CaSR polymorphisms and biochemical markers. The present study is the first to show that CaSR polymorphisms in both codon 990 and intron 4 were closely associated with themagnitude of PTH secretion and thus the clinical severity in primary and secondary HPT patients. These polymorphisms would partly exsplain the heterogeneity of pathological severity in these diseases. As for bone, we demonstrated that both p42/44 and p38 MAP kinase cascades play pivotal roles in CaSR-stimulated mitogenic responses. Moreover, we also obtained data indicating a functional role of CaSR in the regulation of osteoblast function. Less
期刊论文(29)
专著(0)
科研奖励(0)
会议论文
Nakaoka D: "Evaluation of changes in bone density and biochemical parameters after parathyroidectomy in primary hyperparathyroidism"Endocvine J. 47・3. 231-237 (2000)
Nakaoka D:“原发性甲状旁腺功能亢进症甲状旁腺切除术后骨密度和生化参数变化的评估”Endocvine J. 47・3(2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Bastepe M, Pincus JE, Sugimito T, Tojo K, Kanatani M, Azuma Y, Kruse K, Rosenbloom AL, Koshiyama H, Juppner H: "Positional dissociation between the genetic mutation responsible for pseudohypoparathyroidism type lb and the associated methylation defect at
Basstepe M、Pincus JE、Sugimito T、Tojo K、Kanatani M、Azuma Y、Kruse K、Rosenbloom AL、Koshiyama H、Juppner H:“导致 lb 型假性甲状旁腺功能减退症的基因突变与相关甲基化缺陷之间的位置分离
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nakaoka D, Sugimoto T, Kobayashi T, Yamaguchi T, Kobayashi A, Chihara K.: "Prediction of bone mass change after parathyroidectomy in patients with primary hyperparathyroidism"J Clin Endocrinol Metab. 85. 19001-1907 (2000)
Nakaoka D、Sugimoto T、Kobayashi T、Yamaguchi T、Kobayashi A、Chihara K.:“原发性甲状旁腺功能亢进症患者甲状旁腺切除术后骨量变化的预测”J Clin Endocrinol Metab。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kanzawa M, Sugimoto T, Kobayashi T, Kobayashi A, Chihara K: "Association of parathyroid hormone (PTH)/PTH-related peptide receptor gene polymorphism with the extent of bone mass reduction in primary hyperparathyroidism"Horm Metab Res. 32. 355-358 (2000)
Kanzawa M、Sugimoto T、Kobayashi T、Kobayashi A、Chihara K:“甲状旁腺激素(PTH)/PTH相关肽受体基因多态性与原发性甲状旁腺功能亢进症骨质减少程度的关联”Horm Metab Res。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
28
    Elucidation of bone formation signal aimed at the development of medical treatment of osteoporosis induced by deterioration of bone formation
    • 批准号:
      22590656
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2010
    • 负责人:
      SUGIMOTO Toshitsugu
    • 依托单位:
    Research for the elucidation of bone formation signals applied to the development of bone-forming agents
    • 批准号:
      18591025
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.39万
    • 财政年份:
      2006
    • 负责人:
      SUGIMOTO Toshitsugu
    • 依托单位:
    Research for the mechanisms of anabolic action of parathyroid hormone(PTH) on bone and interaction between PTH and estrogen in osteoblasts
    • 批准号:
      14571064
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2002
    • 负责人:
      SUGIMOTO Toshitsugu
    • 依托单位:
    Research for the mechanisms of anabolic action of parathyroid hormone (PTH) and interaction between PTH and estrogen
    • 批准号:
      09671060
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.79万
    • 财政年份:
      1997
    • 负责人:
      SUGIMOTO Toshitsugu
    • 依托单位:
    国内基金
    海外基金
    无脊椎动物新型受体Parathyroid hormone receptor like (PTHRL) 的鉴定及其对赤拟谷盗表皮发育的调控
    • 批准号:
      31872970
    • 项目类别:
      面上项目
    • 资助金额:
      59.0万元
    • 批准年份:
      2018
    • 负责人:
      李斌
    • 依托单位: